MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJohn Paul II Hospital, Krakow

About this trial

All-comer study of unselected patients suitable for carotid artery revascularization to evaluate the feasibility, efficacy and safety of first line endovascular revasculariztion using MicroNet covered stent (CGuard™) in the treatment of consecutive symptomatic and increased-stroke-risk asymptomatic carotid lesions that require revascularization by Neurovascular Team decision.

Eligibility criteria

Qualifiers

Patient > 18 years old qualified by NeuroVascular Team for carotid revascularization according to local standards of care

Signed informed consent

Agreement (routin un this group of patients) to clinical and ultrasonographis follow up.

De-novo atherosclerotic lesions or neo-atherosclerosis

Disqualifiers

Lack of NeuroVascular Team agreement on carotid revascularization indication

Lack of signed informed consent

Estimated life expectancy less than 1 year

Chronic renal failure with serum creatinine level > 3.0 mg/dL

Trial design

Treatments tested in this trial

  • Carotid Artery Stenting

Treatment groups

550 Participants
are divided into 1 treatment group

Sponsors and collaborators

John Paul II Hospital, Krakow

Lead sponsor

Jagiellonian University

Collaborator